BioStem Technologies, Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care. Since our founding in 2014, we’ve pursued a singular goal: changing lives for the better with the power of superior processes and an unwavering commitment to innovation.
Leveraging our proprietary BioRetain® processing method, we manufacture perinatal tissue allografts at the highest levels of quality. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining natural growth factors and preserving tissue structure. Our allografts, including VENDAJE®,VENDAJE AC®, and VENDAJE OPTIC®, are trusted by top clinicians across a range of specialties.